Wilms Tumor 1-Antisense RNA (WT1-AS)

Wilms Tumor 1-Antisense RNA (WT1-AS) is a long non-coding RNA transcribed from the antisense strand of the Wilms Tumor 1 (WT1) gene locus on chromosome 11p13. It functions as a critical epigenetic and post-transcriptional regulator of the WT1 sense gene and various oncogenic or tumor-suppressive pathways. WT1-AS acts primarily as a molecular decoy or "sponge" for several microRNAs, such as miR-494-3p and miR-203a-5p, thereby modulating the expression of downstream targets like PTEN and FOXN2. Depending on the cellular context and tissue type, WT1-AS can exhibit dual roles, acting as an oncogene in malignancies like acute myeloid leukemia and lung cancer, or as a tumor suppressor in others like gastric and cervical cancer. Dysregulation of WT1-AS is closely linked to tumor progression, metastasis, and chemoresistance, making it a valuable prognostic biomarker and a promising therapeutic target. Strategies for targeting WT1-AS include nucleic acid-based interventions such as antisense oligonucleotides and RNA interference, which aim to modulate its levels to inhibit tumor growth or reintroduce cellular differentiation. Research indicates that silencing WT1-AS can sensitize tumor cells to conventional chemotherapeutic agents like doxorubicin and cisplatin. Its role in embryonic development and its tissue-specific expression patterns highlight both its potential as a precision medicine target and the necessity for targeted delivery systems to minimize off-target effects.

Other names

Wilms Tumor 1 Antisense RNA 1WT1-AS1WIT1WIT-1WT1 antisense RNAAntisense non-coding RNA in the Wilms' tumor 1 gene

Drugs targeting WT1-AS typically utilize antisense-mediated degradation or RNA interference (RNAi) to silence its expression, thereby disrupting its role as a molecular decoy or regulator of the WT1 sense gene. This leads to the restoration of microRNA-mediated repression of oncogenic targets or the inhibition of stemness-associated signaling pathways, ultimately inducing cell cycle arrest and apoptosis in malignant cells.